drugset / Trial / NCT07635459

Thermosensitive Gel Nasal Spray With Exosomes, Azelastine, and Interferon for Acute Phase of Chronic Sinusitis

NCT07635459

Phase 0 Not yet recruiting 108 enrolled The First Affiliated Hospital of Xinxiang Medical College
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study tests a new nasal spray for adults (18-65 years) with chronic sinusitis experiencing an acute phase. The spray contains a temperature-sensitive gel that turns into a soft gel inside the nose to slowly release three active ingredients: stem cell exosomes (to repair nasal lining), azelastine (an antihistamine and anti-inflammatory drug), and interferon alpha-2b (an antiviral agent). The study aims to evaluate safety and see if the spray can reduce symptoms, fight viruses, and improve quality of life. Participants will be randomly assigned to one of three groups: triple spray, dual spray (without exosomes), or placebo (gel only). Treatment is twice daily for 4 weeks, with follow-up visits up to day 90.

Timeline

Start
2026-07-01
Primary completion
2027-06-30
Completion
2027-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelastine Small molecule 0.2 mg Intranasal
Subject Exosomes Other / unclassified 2e+09 unknown Intranasal
Subject interferon alfa-2b Protein / enzyme biologic 2000 iu Intranasal